ESMO publishes updated guidelines on cancer careJuly 09, 2010
The European Society for Medical Oncology (ESMO) just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.
The ESMO Clinical Practice Guidelines (CPG) offer vital, evidence-based information including the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up.
Formerly known as the ESMO Clinical Recommendations, the ESMO Clinical Practice Guidelines are intended to provide users with a set of requirements for the highest standard of care for cancer patients.
"The Clinical Practice Guidelines are central to ESMO's mission, which is to advance cancer care and cure through fostering and disseminating good science that leads to better medicine and determines best practice," said ESMO President Prof David Kerr.
A growing number of the new guidelines have been developed using large, multidisciplinary writing groups, ensuring optimal input from the oncology profession and a better geographic representation.
"ESMO is constantly striving to improve the care of cancer patients worldwide," said Prof Kerr. "By developing these new guidelines with the assistance of a wide range of clinicians we can help share the joint expertise of the world's best doctors from many disciplines."
The ESMO Clinical Practice Guidelines include guidelines for breast cancer, colorectal cancer and non-small-cell lung cancer that have been expanded to include more treatment details and further discussion of the importance of multidisciplinary plans for particular patient settings.
Lung cancer is now dealt with in two distinct guidelines, one covering early and locally-advanced cancer, while the other focuses on metastatic disease.
One new guideline is focused specifically on cardiotoxicity, a potential side-effect of some chemotherapeutic agents.
Four further guidelines have been rewritten, drawing on the knowledge of the global oncology community. These include guidelines on soft tissue sarcoma and bone sarcoma, and a guideline on the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
The guideline on the prevention of chemotherapy- and radiotherapy-induced nausea was developed as the result of the 3rd Perugia Consensus Conference organized by the Multinational Association of Supportive Care in Cancer (MASCC) and ESMO.
"ESMO is striving to further increase the value of its guidelines by introducing a more multidisciplinary approach in their development, not only through the use of physical meetings but also through the ESMO Professional Networking Community," said Prof Kerr.
Other guidelines have also been reviewed:
* Pancreatic cancer: including more detail relating to treatment planning in all stages of the disease.
* epatacellular cancer: including an expanded section in surgical and medical treatment, especially targeted therapy.
* Multiple myeloma: revised according to new drug indications.
* Gastrointestinal stromal tumors (GIST): revised with more treatment-orientated details.
* Cancer, fertility and pregnancy: including more information on treatment, especially surgery and highlighting problems of breast, cervical and myeloma cancer in pregnancy as well as further details about delivery of chemotherapy, hormonal and targeted therapy, radiotherapy and supportive agents in pregnant women with cancer.
* Endometrial cancer: including a new section of histology and further guidance on treatment options in these settings.
* Management of febrile neutropenia: including more detail on treatment assessments and how to manage patients.
The new guidelines published in June represent the first stage of a process that will include guidelines for more than 55 different clinical situations, covering almost all tumor types as well as various other topics, including the therapeutic use of growth factors.
European Society for Medical Oncology
Related Clinical Practice Current Events and Clinical Practice News Articles
Unexplained chronic cough treatment subject of updated evidence-based guideline
Persistent, unexplained cough is a significant health issue that occurs in up to 5-10 percent of patients seeking medical assistance for chronic cough.
Lung cancer screening programs do not increase rates of unnecessary surgeries
Lung cancer screening programs that utilize standardized reporting and include cardiothoracic surgeons as part of a multidisciplinary team can successfully be adopted into clinical practice without an increase in surgical intervention for non-cancerous disease, according to an article in the October 2015 issue of The Annals of Thoracic Surgery.
Primary healthcare providers urged to screen teens for depression and suicide risk
A new paper from nursing researchers with The University of Texas at Arlington and Texas Woman's University finds that depression and suicide risk screening can assist healthcare providers in preventing suicides in teens.
Chemical exposure linked to rising diabetes, obesity risk
Emerging evidence ties endocrine-disrupting chemical exposure to two of the biggest public health threats facing society - diabetes and obesity, according to the executive summary of an upcoming Scientific Statement issued today by the Endocrine Society.
Breakthrough study demonstrates survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients
For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.
Differences found between smokers and non-smokers who develop lung cancer
Tobacco smoke is known to be the main risk factor for non-small cell lung cancer (NSCLC), although non-smokers can get it too.
Weight loss, exercise improve fertility in women with PCOS
Weight loss and exercise improve ovulation in women who have polycystic ovary syndrome, a common hormone disorder that often causes infertility, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Guideline released on minimally invasive procedure, EBUS-TBNA, to diagnose lung diseases
The American College of Chest Physicians announced the release of new clinical guidelines on endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA).
Combination drug treatment reduces agitation for patients with probable Alzheimer's disease
In a preliminary 10-week randomized trial, patients with probable Alzheimer disease who received the combination medication dextromethorphan-quinidine demonstrated less occurrences and severity of agitation, compared to patients who received placebo, according to a study in the September 22/29 issue of JAMA.
Tracking down the beam
Proton beams are new high-precision weapons in the fight against cancer. However, uncertainty with regard to the range of the beams has prevented the full exploitation of the potential of this method until now.
More Clinical Practice Current Events and Clinical Practice News Articles